Em Empowering H Health th Supporting Innovation Dr r Nic Nic Woods Health Lead, Microsoft Australia
A little about me Assoc. Professor Jared Dart BSc BA (Econ, Govt) M.B.B.S. PhD (eHealth, Medicine) FRACGP Chief Medical Officer Passionate about solving complex problems for the benefit of • society and individuals
Primary Care The Centre of the Universe PHARMACY GENERAL PRACTICE Referral 54/100 19,000 Pharmacists • $18Bn • 130MM consults • 270MM prescriptions • 26,000 GPs $10.4B • <25 years = 21.1% • SPECIALIST • 25-44 years = 22.9% Referral 8.1/100 Discharge ~100% 45 – 64 = 28.2% • 25,400 specialists • 9.3MM Admissions • 65+ years = 27.8% • 40%+ chronic conditions • HOSPITAL AND ACUTE Referral 0.3/100 Emergency 6.5MM • Discharge ~100% 1/5 Admitted •
Old News • Telehealth is not new, nor even recent Th The Radio Doctor April, 1924, Radio News Magazine
‘Virtual’ care • Seems to suggest exclusion of the HCP • ‘Technology enhanced care’ may be more appropriate Di Diagnosis b by R Radio February, 1925, Science and Invention magazine
Furious Agreement The eHealth has Using POTENTIAL FOR NEW POTENTIAL TO IMPROVE TELEHEALTH INITIATIVES IN THE HEALTH OUTCOMES AT TECHNOLOGY TELEHEALTH ARENA ALL LEVELS to help the chronically ill to IS VAST from preventative health, specialist monitor and manage their as is the potential for enabling and acute care and self-management condition at home could almost patients with special needs (such as of chronic conditions, through to halve mortality rates and save the the elderly or those with limited home monitoring for people living health budget mobility) to gain better access to up to $3 billion a year with disabilities primary healthcare https://ama.com.au/sites/default/files/documents/Better%20access https://blog.csiro.au/smart-technologies-can-fix-our- www.racgp.org.au/download/Documents/Standards2011standardsforv %20to%20high%20speed%20broadband%20Position%20Statement. bleeding-healthcare-system/ ideoconsultations.pdf pdf
A little about Welio In In 2016 We Welio partnered with Micr crosoft to co-de develop a p a v virt rtua ual c care pl platform rm f for he r health c h care pr professiona nals, g , given; n; 1. technology based patient consultations are already occurring but in a sub-optimal fashion o security/privacy is adhoc and not at global HIPAA standard o cost-recoverability and chargeability substandard o clinician-driven, patient-centric additional functions (e.g self-directed care) lacking 2. these are soluble issues which if addressed can enhance both clinical and commercial outcomes
The ‘We’ in Welio Collaboration will drive clinical uptake so everyone is invited. Have (and will continue to) taken input from ecosystem stakeholders; Practices – doctor owned, small group practice, corporate practices • Health Insurers • Medical indemnity provider • Peak representative bodies including AMA, RACGP, ACRRM, RANZCP, APA and others • Government • Academia • The broader eHealth industry •
Research: GPs and TBPC Survey via The Medical Republic N= 97 on Technology Based Patient Consultations (TBPC), Welio and how/where it can add value. ‘patient consultations that use any form of technology, including, but not restricted to videoconferencing, internet and telephone, as an alternative to face-to-face consultations Me Medical Board of Australia
Current use of TBPC Use of Live Video Current use of TBPC (unsecured) (any form) 28 % 66 %
Could have used Welio (%age of last 100 patients) Of your last 100 patients, what proportion could have been conducted via Welio? UP TO 10% 10-20% MORE THAN 20% 0% 5% 10% 15% 20% 25% 30% 35% 40% Source: TMR GP Survey (n=97)
GP Interest rates 8 out of 10 • 43% of GPs rate their level of interest between 8 and 10 on a 10 point scale. • Regardless of city or rural
How secure is it really? Majority of • Concern for liability clinicians rate • Welio is HIPAA compliant; highest level of security security as possible, unprecedented in Australia mission-critical
Above all do no harm Clinican concerns • Concern for going beyond clinical remit around use of virtual overextending care relate to • Concern for liability missing something (in the absence of • Welio initial use in chronic disease follow up physical exam) • Use is covered under professional indemnity insurance
Not relevant to all consults • Welio is designed for use by the patients usual practice and ideally their usual GP Welio will augment but • In some situations there is no substitute for an in-person consultation and video consultations should be avoided. cannot replace • New patients that the HCP doesn’t know and can’t HCP examine • New symptoms in existing patients that require a physical examination
Future functionality • Activate self-directed care kits developed by independent, credible peak bodies nationwide To be deployed • Monitor biometric data from compatible mHealth devices if our pilot HCPs • Instantly message patients and care team members see value • Generate evidence-based chronic disease management plans with a single touch • Seamlessly connect and refer patients for speciality consultations
Where to next? AI. • Artificial intelligence We have the • Bots technology. • Deep and predictive learning • Mixed reality Utility needs to be determined
Introducing nationwide piloting
Independent validation via academic partner
Pilot and development program Objectives of the Welio pilot and development program are: Implementation and feasibility To ensure / demonstrate that Welio integrates seamlessly into the clinical processes currently employed by GPs Acceptability and Effectiveness To demonstrate the effectiveness of Welio Consultation in the real world a. Demonstrate that Welio consultations are not inferior to a face to face consultation b. Identify the circumstances where Welio consultations are superior to a face to face consultation
Want to help shape the future of virtual care? HCPs and related organisations can register at welio.com
Recommend
More recommend
